Literature DB >> 8912520

Development of amyloidosis as an unrecognized side effect of gold therapy: comment on the article by Shapiro and Spiera.

H Michels, R P Linke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912520     DOI: 10.1002/art.1780391126

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  1 in total

1.  The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

Authors:  Piotr Wiland; Renata Wojtala; John Goodacre; Jacek Szechinski
Journal:  Clin Rheumatol       Date:  2004-02-26       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.